Together, these results indicate that the CSF2RB gene potentially plays i) a protective or tumor-suppressive role in luminal and HER2+ subtypes and ii) an oncogenic role in triple-negative breast cancers (TNBC). The gene discussed is CSF2RB; the disease is triple-negative breast carcinoma.